Adipose-derived stem cells (ASCs) are mesenchymal stem cells

Posted by Coherent Market insights on May 10th, 2022

Adipose-derived stem cells (ASCs) are mesenchymal stem cells (MSCs) produced from adipose tissue that are adhesive to plastic culture flasks, can be grown in vitro, and can develop into several cell lineages. Unlike MSCs generated from bone marrow, ASCs can be extracted from plentiful adipose tissue using a minimally invasive method that yields a large number of cells. As a result, ASCs hold promise for rebuilding tissues and organs that have been damaged by injury or disease. The implications of ASCs in tissue regeneration are discussed in this article.

Adipose-derived stem cell therapy is a groundbreaking regenerative medicine technique that employs fat cells or adipose cells to repair damaged or degenerative cells in the body and promote healing. This method employs cutting-edge techniques to provide patients with the astonishing benefits of medical breakthroughs in stem cell technology and research.

Read more: https://tradove.com/blog/Adipose-derived-stem-cell-therapy-eliminates-the-risk-of-rejection-and-transmission-of-disease.html